NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER

A furazan-3-carboxylic acid derivative or pharmaceutically acceptable salt thereof for treatment of acute myeloid leukemia..

Medienart:

Patent

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Europäisches Patentamt - (2018) vom: 12. Apr. Zur Gesamtaufnahme - year:2018

Sprache:

Englisch

Beteiligte Personen:

RADEMANN JÖRG [VerfasserIn]
WONG EE LIN [VerfasserIn]
ARKONA CHRISTOPH [VerfasserIn]
KIM BOO GEUN [VerfasserIn]
NAWROTZKY ERIC [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
C07D: Heterocyclic compounds (macromolecular compounds c08)
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2018-04-12, Last update posted on www.tib.eu: 2022-10-26, Last updated: 2023-02-09

Patentnummer:

WO2018065536

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA006306578